Aimovig

Aimovig Overdosage

erenumab

Manufacturer:

Novartis

Distributor:

Zuellig Pharma
Full Prescribing Info
Overdosage
No cases of overdose have been reported in clinical studies.
Doses up to 280 mg have been administered subcutaneously in clinical studies with no evidence of dose-limiting toxicity.
In the event of an overdose, the patient should be treated symptomatically and supportive measures instituted as required.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in